40:
185:
are frequently reported in association with carcinocythemia. The prognosis is poor: a review of 26 patients found that 85% died within 6 months of the diagnosis, with an average time of 6.1 weeks between diagnosis and death.
189:
The amount of tumour cells on the blood smear can range from 1 to 80 percent of the total white blood cell count, with lower percentages being more common. Carcinocythemia is distinct from the presence of
765:
Chang, Yuan-Hsin; Hsieh, Ruey-Kuen; Chang, Ming-Chi; Chen, Gon-Shen (2007). "Breast cancer with an unusual leukemia-like presentation: case report and literature review".
153:. It is an extremely rare condition, with 33 cases identified in the literature from 1960 to 2018. Carcinocythemia typically occurs secondary to infiltration of the
264:. Tumour cells are often found at the edge of the blood smear due to their large size, so this area should be examined thoroughly if carcinocythemia is suspected.
972:
Sá e Lemos, Eva; Lima de
Carvalho, Hugo; Gil da Costa, Rui M.; Pinto da Cunha, Nazaré (2018). "Carcinocythemia: First report in a cat and literature review".
194:(CTCs), as CTCs usually occur in such low quantities that they cannot be seen on blood smear examination, requiring special techniques for detection.
847:
685:
657:
658:
Michael
Caligiuri; Marcel M. Levi; Kenneth Kaushansky; Marshall A. Lichtman, Josef Prchal, Linda J Burns, Oliver W Press (23 December 2015).
941:
924:
861:
Ashworth, T.R. (1869). "(1869) A Case of Cancer in Which Cells
Similar to Those in the Tumours Were Seen in the Blood after Death".
389:
Ogura, Kanako; Amano, Maki; Matsumoto, Toshiharu; Sakaguchi, Asumi; Kosaka, Taijiro; Kitabatake, Toshiaki; Kojima, Kuniaki (2015).
573:"Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review"
182:
880:
Carey, Robert W.; Taft, Priscilla D.; Bennett, John M.; Kaufman, Sheldon (1976). "Carcinocythemia (carcinoma cell leukemia)".
669:
642:
530:
365:
was first used in 1976 by Robert Carey. In 1984, a review of 10 cases was published, noting the condition's poor prognosis.
39:
355:
The presence of tumour cells in the peripheral blood of a cancer patient was first described in an 1869 case report in the
291:
1017:
245:
cells. Features that aid in distinguishing tumour cells from other cells include their very large size, mature
290:, a profile that is non-specific but unusual for hematologic malignancies. In some cases, flow cytometry and
357:
256:, and their tendency to appear in clumps or clusters, although some of these characteristics are shared by
202:
The mechanism of carcinocythemia is poorly understood. Some patients with carcinocythemia show evidence of
207:
571:
Ronen, Shira; Kroft, Steven H.; Olteanu, Horatiu; Hosking, Paul R.; Harrington, Alexandra M. (2019).
1032:
191:
815:
301:
1042:
925:"Carcinocythemia (carcinoma cell leukemia). Report of two cases with english literature review"
632:
174:
150:
87:
518:
373:
As of 2018, there were two documented cases of carcinocythemia in dogs and one case in a cat.
841:
391:"Occult Breast Lobular Carcinoma with Numerous Circulating Tumor Cells in Peripheral Blood"
271:
8:
227:
798:
738:
679:
630:
610:
425:
390:
341:
267:
100:
1037:
997:
989:
954:
946:
905:
897:
893:
829:
790:
782:
730:
722:
665:
638:
602:
594:
526:
484:
476:
430:
412:
275:
158:
76:
56:
971:
802:
742:
614:
981:
936:
889:
774:
712:
584:
466:
420:
402:
328:
214:
of malignant cells, could contribute to the presence of tumour cells in the blood.
108:
659:
471:
454:
942:
10.1002/1097-0142(19840301)53:5<1100::AID-CNCR2820530514>3.0.CO;2-K
316:
279:
257:
146:
92:
778:
1026:
993:
950:
901:
786:
726:
631:
Noel
Weidner; Richard J. Cote; Saul Suster; Lawrence M. Weiss (8 July 2009).
598:
480:
416:
332:
230:. If the number of suspicious cells is low, a smear can be prepared from the
170:
112:
48:
1001:
794:
734:
606:
488:
434:
322:
211:
203:
104:
1018:
Images of carcinocythemia at the
American Society of Hematology image bank
958:
909:
833:
817:
816:
Lugassy G, Vorst EJ, Varon D, Sigler E, Shani A, Bassous-Guedj L. (1990).
516:
407:
818:"Carcinocythemia. Report of two cases, one simulating a Burkitt lymphoma"
304:
is indicated in carcinocythemia to better characterize the tumour cells.
295:
250:
223:
154:
80:
717:
700:
589:
572:
336:
238:
231:
178:
116:
61:
985:
312:
Carcinocythemia must be distinguished from the following conditions:
261:
253:
246:
123:
298:
and chromosomal abnormalities associated with hematologic diseases.
294:
results may be misleading, as circulating tumour cells can exhibit
242:
96:
65:
517:
Irma
Pereira; Tracy I. George; Daniel A. Arber (7 December 2011).
237:
Tumour cells in peripheral blood may look similar to circulating
701:"The emerging role of circulating tumor cells in breast cancer"
142:
274:
techniques can help determine the lineage of the cells. When
388:
287:
283:
177:, and usually appears late in the course of the disease.
570:
879:
523:
Atlas of
Peripheral Blood: The Primary Diagnostic Tool
47:
A case of carcinocythemia. The large, round cells are
525:. Lippincott Williams & Wilkins. pp. 185–7.
206:, and it has been suggested that dysfunction of the
764:
452:
916:
519:"Chapter 20: Nonhematopoietic tumors in the blood"
923:Gallivan, Monica V. E.; Lokich, Jacob J. (1984).
626:
624:
566:
564:
562:
453:Johnsrud, Andrew J.; Pina-Oviedo, Sergio (2017).
1024:
760:
758:
756:
754:
752:
692:
651:
560:
558:
556:
554:
552:
550:
548:
546:
544:
542:
141:, is a condition in which cells from malignant
922:
621:
577:International Journal of Laboratory Hematology
448:
446:
444:
234:of the blood sample to concentrate the cells.
873:
749:
698:
539:
512:
510:
508:
506:
504:
502:
500:
498:
382:
222:Carcinocythemia can be detected on a routine
965:
854:
846:: CS1 maint: multiple names: authors list (
684:: CS1 maint: multiple names: authors list (
637:. Elsevier Health Sciences. pp. 1593–.
455:"Carcinocythemia (carcinoma cell leukemia)"
441:
809:
495:
51:cells circulating in the peripheral blood.
38:
940:
716:
588:
470:
424:
406:
307:
860:
321:Circulating immature cells secondary to
169:Carcinocythemia occurs most commonly in
1025:
664:. McGraw-Hill Education. p. 658.
183:disseminated intravascular coagulation
161:and carries a very poor prognosis.
128:Poor; 15% survival rate at 6 months
13:
103:, circulating immature cells from
14:
1054:
1011:
882:The American Journal of Medicine
863:The Medical Journal of Australia
368:
699:Krishnamurthy, Savitri (2012).
164:
1:
974:Veterinary Clinical Pathology
376:
894:10.1016/0002-9343(76)90437-X
472:10.1182/blood-2017-08-799882
358:Medical Journal of Australia
217:
197:
7:
16:Tumour cells on blood smear
10:
1059:
350:
282:, the cells are generally
208:reticuloendothelial system
149:origin are visible on the
779:10.1007/s12032-007-0048-2
634:Modern Surgical Pathology
395:Case Reports in Pathology
286:negative and may express
122:
86:
71:
55:
46:
37:
29:
24:
204:impaired spleen function
192:circulating tumour cells
661:Williams Hematology, 9E
302:Bone marrow examination
139:carcinoma cell leukemia
33:Carcinoma cell leukemia
308:Differential diagnosis
175:small cell lung cancer
151:peripheral blood smear
88:Differential diagnosis
268:Cytochemical staining
75:Usually secondary to
705:Cancer Cytopathology
272:immunohistochemistry
408:10.1155/2015/135684
228:manual differential
718:10.1002/cncy.20207
590:10.1111/ijlh.12924
342:Leukemoid reaction
101:leukemoid reaction
986:10.1111/vcp.12565
671:978-0-07-183300-4
644:978-1-4377-1958-1
532:978-1-4511-6366-7
329:endothelial cells
247:nuclear chromatin
159:metastatic cancer
132:
131:
109:endothelial cells
77:metastatic cancer
19:Medical condition
1050:
1006:
1005:
969:
963:
962:
944:
935:(5): 1100–1102.
920:
914:
913:
877:
871:
870:
858:
852:
851:
845:
837:
813:
807:
806:
767:Medical Oncology
762:
747:
746:
720:
696:
690:
689:
683:
675:
655:
649:
648:
628:
619:
618:
592:
568:
537:
536:
514:
493:
492:
474:
450:
439:
438:
428:
410:
386:
276:immunophenotyped
137:, also known as
42:
22:
21:
1058:
1057:
1053:
1052:
1051:
1049:
1048:
1047:
1033:Hematopathology
1023:
1022:
1014:
1009:
970:
966:
921:
917:
878:
874:
859:
855:
839:
838:
814:
810:
763:
750:
697:
693:
677:
676:
672:
656:
652:
645:
629:
622:
569:
540:
533:
515:
496:
451:
442:
387:
383:
379:
371:
363:carcinocythemia
353:
310:
258:megakaryoblasts
226:examination or
220:
200:
167:
135:Carcinocythemia
25:Carcinocythemia
20:
17:
12:
11:
5:
1056:
1046:
1045:
1040:
1035:
1021:
1020:
1013:
1012:External links
1010:
1008:
1007:
980:(1): 142–145.
964:
915:
888:(2): 273–278.
872:
853:
808:
773:(1): 100–103.
748:
711:(3): 161–166.
691:
670:
650:
643:
620:
538:
531:
494:
440:
380:
378:
375:
370:
367:
352:
349:
348:
347:
344:
339:
333:megakaryocytes
325:
319:
317:Acute leukemia
309:
306:
280:flow cytometry
219:
216:
199:
196:
173:, followed by
166:
163:
130:
129:
126:
120:
119:
113:megakaryocytes
107:, circulating
93:Acute leukemia
90:
84:
83:
73:
69:
68:
59:
53:
52:
44:
43:
35:
34:
31:
27:
26:
18:
15:
9:
6:
4:
3:
2:
1055:
1044:
1043:Rare diseases
1041:
1039:
1036:
1034:
1031:
1030:
1028:
1019:
1016:
1015:
1003:
999:
995:
991:
987:
983:
979:
975:
968:
960:
956:
952:
948:
943:
938:
934:
930:
926:
919:
911:
907:
903:
899:
895:
891:
887:
883:
876:
868:
864:
857:
849:
843:
835:
831:
827:
823:
819:
812:
804:
800:
796:
792:
788:
784:
780:
776:
772:
768:
761:
759:
757:
755:
753:
744:
740:
736:
732:
728:
724:
719:
714:
710:
706:
702:
695:
687:
681:
673:
667:
663:
662:
654:
646:
640:
636:
635:
627:
625:
616:
612:
608:
604:
600:
596:
591:
586:
582:
578:
574:
567:
565:
563:
561:
559:
557:
555:
553:
551:
549:
547:
545:
543:
534:
528:
524:
520:
513:
511:
509:
507:
505:
503:
501:
499:
490:
486:
482:
478:
473:
468:
464:
460:
456:
449:
447:
445:
436:
432:
427:
422:
418:
414:
409:
404:
400:
396:
392:
385:
381:
374:
369:Other animals
366:
364:
360:
359:
345:
343:
340:
338:
334:
330:
326:
324:
320:
318:
315:
314:
313:
305:
303:
299:
297:
293:
289:
285:
281:
277:
273:
269:
265:
263:
259:
255:
252:
248:
244:
240:
235:
233:
229:
225:
215:
213:
210:, preventing
209:
205:
195:
193:
187:
184:
180:
176:
172:
171:breast cancer
162:
160:
156:
152:
148:
147:hematopoietic
144:
140:
136:
127:
125:
121:
118:
114:
110:
106:
102:
98:
94:
91:
89:
85:
82:
78:
74:
70:
67:
63:
60:
58:
54:
50:
49:breast cancer
45:
41:
36:
32:
28:
23:
977:
973:
967:
932:
928:
918:
885:
881:
875:
866:
862:
856:
842:cite journal
828:(2): 265–8.
825:
821:
811:
770:
766:
708:
704:
694:
660:
653:
633:
583:(1): 69–79.
580:
576:
522:
465:(21): 2357.
462:
458:
398:
394:
384:
372:
362:
356:
354:
327:Circulating
323:chemotherapy
311:
300:
296:cell markers
266:
236:
221:
212:phagocytosis
201:
188:
168:
165:Presentation
138:
134:
133:
105:chemotherapy
361:. The term
337:osteoclasts
224:blood smear
155:bone marrow
117:osteoclasts
81:bone marrow
30:Other names
1027:Categories
869:: 146–147.
822:Acta Cytol
377:References
262:monoblasts
251:vacuolated
249:pattern,
232:buffy coat
179:Thrombosis
62:Hematology
994:0275-6382
951:0008-543X
902:0002-9343
787:1357-0560
727:1934-662X
680:cite book
599:1751-5521
481:0006-4971
417:2090-6781
254:cytoplasm
218:Diagnosis
198:Mechanism
124:Prognosis
57:Specialty
1038:Leukemia
1002:29360147
803:20417675
795:18188722
743:36422597
735:22275137
615:52278041
607:30216684
489:29170195
435:26199779
346:Lymphoma
243:lymphoma
97:lymphoma
66:oncology
959:6362836
910:1062163
834:2157324
426:4496473
401:: 1–6.
351:History
145:of non-
143:tumours
79:in the
1000:
992:
957:
949:
929:Cancer
908:
900:
832:
801:
793:
785:
741:
733:
725:
668:
641:
613:
605:
597:
529:
487:
479:
433:
423:
415:
239:blasts
72:Causes
799:S2CID
739:S2CID
611:S2CID
459:Blood
998:PMID
990:ISSN
955:PMID
947:ISSN
906:PMID
898:ISSN
848:link
830:PMID
791:PMID
783:ISSN
731:PMID
723:ISSN
686:link
666:ISBN
639:ISBN
603:PMID
595:ISSN
527:ISBN
485:PMID
477:ISSN
431:PMID
413:ISSN
399:2015
292:FISH
288:CD56
284:CD45
270:and
260:and
181:and
982:doi
937:doi
890:doi
775:doi
713:doi
709:120
585:doi
467:doi
463:130
421:PMC
403:doi
335:or
278:by
241:or
157:by
115:or
1029::
996:.
988:.
978:47
976:.
953:.
945:.
933:53
931:.
927:.
904:.
896:.
886:60
884:.
867:14
865:.
844:}}
840:{{
826:34
824:.
820:.
797:.
789:.
781:.
771:25
769:.
751:^
737:.
729:.
721:.
707:.
703:.
682:}}
678:{{
623:^
609:.
601:.
593:.
581:41
579:.
575:.
541:^
521:.
497:^
483:.
475:.
461:.
457:.
443:^
429:.
419:.
411:.
397:.
393:.
331:,
111:,
99:,
95:,
64:,
1004:.
984::
961:.
939::
912:.
892::
850:)
836:.
805:.
777::
745:.
715::
688:)
674:.
647:.
617:.
587::
535:.
491:.
469::
437:.
405::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.